A Phase 2b clinical trial (Heffernan 2007, 300 obese patients) tested 1 mg/day subcutaneously over 12 weeks with a weight loss result of ~2.8 kg vs placebo
5-Amino-1MQ A small molecule peptide that works by inhibiting NNMT (nicotinamide N-methyltransferase) , which leads to increased NAD+ levels and improved mitochondrial metabolism
AOD-9604 Cycle Length and Protocol Duration Determining optimal cycle length depends on metabolic goals, baseline body composition, response to therapy, and physician assessment
Arginine has also been found to support a reduction in total cholesterol and decreased low density lipoproteins (LDL)
YES NO Didn't find the answer you are looking for
These signs include fatigue, weakness, constipation, reduced appetite, weight loss, along with numbness and tingling sensations in the extremities